About this trial

Purpose: Conduct a wait-list randomized controlled trial (RCT) of an inclusive physical activity program called PACE for adults with intellectual disability (ID) who are not yet showing signs of Alzheimer's Disease (AD)/age-related dementias (ARD).

Participants: Participants include 120 adults with ID, their caregivers, and their coaches (up to 360 individual participants, grouped as triads), recruited through the University of North Carolina at Chapel Hill and the University of Arkansas. Participants also include 16 exercise professionals.

Procedures (methods): Each cohort will include 20 triads who are randomly assigned to the PACE program or the waitlist control group.

Eligibility criteria

Qualifiers

ages 18 and older with a prior clinical diagnosis of ID, confirmed by scores < 70 and + 90% on the Leiter-3 International Performance Scales and/or an adaptive behavior measure using the Vineland Adaptive Behavior Scales,

Medical clearance to participate in moderate-to-vigorous physical activity as determined by the American College of Sports Medicine (ACSM) preparticipation algorithm,

Adult does not show clinically elevated symptoms of Alzheimer's Disease (AD)/ Alzheimer's Disease and Related Dementias (ADRD) as indicated by a score of < 20 on the Dementia Screening Questionnaire for Individuals with Intellectual Disabilities.

One caregiver/guardian is able and willing to participate.

Disqualifiers

access to the internet and a mobile device,

has weekly contact with the adult participant with ID,

can converse and read in English to comprehend intervention materials and website content, and

must reside in North Carolina or Arkansas

Trial design

Treatments tested in this trial

  • PACE Program

Treatment groups

376 Participants
are divided into 2 treatment groups

Locations

2
University of Arkansas72701, FayettevilleArkansas, United States
University of North Carolina27517, Chapel HillNorth Carolina, United States

Sponsors and collaborators

University of North Carolina, Chapel Hill

Lead sponsor

National Institute on Aging (NIA)

Collaborator